Bliss GVS Pharma
BLISSGVS · Pharma > Pharmaceuticals & Drugs · Chairman: S R Vaidya · MD: Gagan Harsh Sharma · Listing date: July 26, 2010 · Employees: 683 · Mumbai · http://www.blissgvs.com

Stock Price vs Company Growth
1d
1.7%
1w
17.5%
1m
34.1%
3m
34.7%
6m
29.0%
1y
58.2%
5y
4.3%
10y
6.7%
all
12.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 218 1.7%
141
225
Company Overview

Sales
868 Cr
Growth: 8.5%
Profit after Tax
109 Cr
Growth: -0.5%
Small Cap
2,306 Cr
P/E: 21.4x
Industry P/E: 29.7x
Fundamentals

Sales (Cr) ₹ 868
Growth 8.5%
EBITDA 14.9%
P/S 2.7x
Dividend 0.4%
P/E 21.4x
Book Value ₹ 108
PEG Ratio 2.5x
ROE 9.9%
P/B 2.0x
Shareholding Pattern

Institutions
Arian Investment Ltd
9.7 %
Life Insurance Corporation Of India
6.68 %
Polus Global Fund
4.62 %
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
2.9 %
Aspire Emerging Fund
2.46 %
Promoters
Narsimha Shibroor Kamath
33.24 %
Others
Gulbarga Trading And Investment Pvt. Ltd.
5.67 %
Arjun Gautam Ashra
4.89 %
Gautam Rasiklal Ashra
2.82 %
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs
2.2 %
Llp
0.05 %
Increase    Decrease    No change
Company Profile Detailed

It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception.
Investors (66)
Followers (10)